Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Xtremity

Explore full profile

A Medical Device brand from Medical Creations Inc

Denver, United StatesHealth Tech & Medtech
Valuation $25–50M Last recorded · 2022
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Xtremity and the history behind them.

About Xtremity

Xtremity, legally known as Medical Creations Inc., is a medical device company focused on advancing prosthetic socket technology. Founded in 2017 by a group of humanitarians and inventor Mark Joseph, the company's origins are rooted in experiences from medical missions in developing nations, which highlighted the need for more accessible prosthetic care. This mission-driven approach led to the development of their core product. In March 2024, Xtremity was acquired by WillowWood Global, a major manufacturer and distributor in the prosthetics industry, integrating Xtremity's technology into a broader portfolio of custom solutions.

The company's business model centers on the sale of its patented prosthetic socket systems to clinicians and prosthetists. Its flagship product is the XtremityTT® Socket System, designed for transtibial (below-the-knee) amputees. The system's unique selling proposition lies in its use of a proprietary, thermoformable carbon-reinforced polymer. This material allows a prosthetist to fabricate, fit, and adjust a definitive socket in about an hour, a significant reduction from the weeks it can take with traditional laminated carbon fiber sockets. This process involves heating a pre-molded socket "preform" and shaping it to the patient's residual limb, which can be done in-clinic with minimal equipment. The key benefit for patients is a reduction in appointments and a more comfortable, adaptable fit, as the socket can be easily heat-adjusted over time to accommodate changes in limb volume. For clinicians, it offers a faster, safer, and more efficient in-house fabrication process, eliminating the need for outside labs and reducing exposure to hazardous materials.

The company has secured significant funding to support its growth, including an $8.1 million Series B3 round in October 2022, which brought its total funding to $27.5 million at the time and was aimed at commercializing the XtremityTT system. The technology has undergone extensive testing, including a 38-patient clinical trial where 81% of users preferred the XtremityTT socket over their previous carbon fiber ones. The product has also been utilized in demanding environments, providing prosthetic solutions for amputees in Ukraine. The acquisition by WillowWood is expected to expand the market reach of Xtremity's technology.

Source: Dealroom company data

At a glance

Headquarters
Denver, United States
Sector
Health Tech & Medtech

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Decheng Capital
Employees 3 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Xtremity on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Xtremity on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.